Objective M1-like inflammatory phenotype of macrophages plays a critical role in tissue damage in chronic inflammatory diseases. Previously, we found that the nitrone spin trap 5,5-dimethyl-1-pyrroline N-oxide (DMPO) dampens lipopolysaccharide (LPS)-triggered inflammatory priming of RAW 264.7 cells. Herein, we tested whether DMPO by itself can induce changes in macrophage transcriptome, and that these effects may prevent LPS-induced activation of macrophages.
Introduction
Inflammation is an essential and protective response of mammalian cells against irritation. However, a chronic inflammatory condition can lead to tissue damage due to an excessive production of reactive biochemical species (RBS) (oxygen-, nitrogen-, sulfur-and halogen-derived reactive species) and inflammatory mediators (cytokines, chemokines and enzymes) [1] . These mediators are mainly produced by innate immune cells, such as macrophages that acquire an inflammatory phenotype at irritated sites. This phenotype of macrophage results from transcriptomic changes towards and inflammatory M1-like profile [2] .
The most well-known model of inflammatory activation of macrophage is the priming of RAW 264.7 cells induced by bacterial lipopolysaccharide (LPS). In macrophages, Gramnegative bacterial LPS is sensed by homo-or hetero-dimeric membrane toll-like receptors (TLR), particularly TLR-4 [3] . Downstream binding of LPS to TLR-4 signaling proceeds throughout both, a MyD88-dependent (TRIF-independent) pathway that includes the activation of MAPK kinases and a TRIF-mediated (MyD88-independent) signaling pathways that include activation interferon regulatory factors (IRFs) [4] . MyD88-dependent pathway ends in nuclear translocation of the master regulator of the inflammatory response, nuclear factor (NF)-ĸB and production of pro-inflammatory cytokines, adhesion molecules and enzymes [5] . TRIFmediated pathway activation results in type-1 interferon secretion and activation of IRFs [6] . Thus, LPS triggers a number of transcriptional changes in macrophages causing its inflammatory priming. These transcriptomic changes are accompanied by an exaggerated production of RBS, which include radical and non-radical species. Reactive oxygen species (ROS), in particular H 2 O 2 , have been suggested as secondary messengers in redox signaling and inflammatory activation of macrophages [7] .
Antioxidants, such as l-ascorbate, urate or glutathione (GSH), can stop free radical reaction throughout becoming itself a free radical by the radical being scavenged and thus regenerating the native molecule [8, 9] . Unlikely those, spin traps are low-molecular-weight compounds that covalently binds to radical sites in small or large radicalized molecules, and thus can stop free radical-chain reactions that otherwise end in end-oxidation products [10] . Among spin traps, nitrone and nitroxide compounds are the most used in free radical research. Nitrone compounds, such as 5,5-dimethyl-1-pyrroline N-oxide (DMPO) and N-tert-butyl-α-phenylnitrone (PBN) offer particular properties that make them suitable for free radical research in cells and organisms. Particularly, DMPO offers interesting properties including low toxicity, known pharmacokinetics, easy diffusion thorough cell membranes and efficient trapping of free radicals [11] [12] [13] .
The nitrones PBN and DMPO have been studied for its antioxidant and anti-inflammatory activities; however, therapeutic properties of DMPO have been far less studied than those of PBN. As to date PBN derivatives, such as NXY-059, have reached phase III in clinical trials [14, 15] . However, in vivo effects of DMPO are ill defined. Limited data have demonstrated that pre-administration of DMPO reduces the mortality associated with endotoxin-induced shock in the rat [16] , and also it has been shown to protect against reperfusion-induced injury or arrhythmias in isolated rat heart models [17] . Most of these effects have been linked to its free radical spin trapping properties.
Using DMPO as a tool we have studied the intracellular localization and identity of radicalized protein and DNA in cells, tissues and whole animals [18, 19] . Previously we showed that DMPO reacts with radicalized proteins inside the cell and prevents its further oxidation in a model of LPS-induced priming of murine macrophage-like cell line RAW 264.7 [20] . Interestingly DMPO dampened macrophage LPS-driven activation involving nitric oxide (NO) and inflammatory chemokine production by inhibition of NF-ĸB signaling pathway at early time points after stimulus (15 min) [21] . These effects cannot be explained by DMPOscavenging ROS, thus interfering in ROS-dependent signaling, because the rate constant of DMPO reacting with superoxide is slower than the reaction constant of DMPO reacting with radicalized proteins [22, 23] . These evidences suggest that the protective effects afforded by DMPO on macrophages are not only linked to its spin-trapping properties.
Herein we used transcriptomic analysis to test whether DMPO causes transcriptional changes that may explain its anti-inflammatory effects on LPS-induced priming of macrophages. This information is critically needed before DMPO or structural analogs proceed to the development of new anti-inflammatory drugs.
Materials and methods

Cell culture
RAW 264.7 cells were obtained from American Type Culture Collection (TIB-71, Rockville, MD) and grown in DMEM-F12 medium supplemented with 10% fetal bovine serum (Natocor, Argentina) at 37 °C in a 5% CO 2 incubator. Cells between passages 4 and 12 were used in this study.
LPS and DMPO treatments
LPS (E. coli serotype 055:B5, Cat# L2637) was from Sigma (St. Louis, MO). DMPO was from Dojindo Molecular Technologies (Cat# D-04810, Kumamoto, Japan). Cells were cultivated on 25-or 75-ml T-flasks and allowed to attach for 24 h, then the medium was removed and replaced with the indicated medium with DMPO and/or LPS. DMPO was used at 50 mM in this study. According to our earlier studies, LPS at 1 ng/ml was a non-cytotoxic concentration that primed RAW 264.7 cell to produce significant nitric oxide (NO) [20] . DMPO was mostly used at 50 mM in this study because it could inhibit LPS (1 ng/ml)-induced priming, without significant cytotoxicity as assessed by trypan blue influx, lactic dehydrogenase release and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)-reduction assay [20] .
NO production assay
Nitrite accumulation in culture medium was measured as an indirect indicator of NO synthesis. 10 5 RAW 264.7 cells were seeded on 96-well microplates and stimulated with different concentration of LPS in the presence or in the absence of 50 mM DMPO for 24 h (final volume 200 µl). After incubation culture medium was collected for nitrite measurement using the Griess reaction. Sodium nitrite was used to produce the standard curve.
RNA isolation for microarray and nCounter experiments
RAW 264.7 cells were incubated in T-75 flask by triplicates with or without 1 ng/ml LPS in the presence or in the absence of 50 mM DMPO. Cells incubated with DMEM culture medium were used as control. After 6 h incubation, cells were washed with PBS, scrapped and pelleted down at 1000g for 5 min. by centrifugation. Resulting pellet was used for RNA extraction using RNAeasy MIDI kit (QUIA-GEN). Purified RNA was quantified using NanoDrop® and quality was assessed using the Bioanalizer® (Agilent, Santa Clara, CA). 50 µg of RNA was then hybridized with a Mouse genome Set microarray chip (Illumina, ver. 6.1-38000 transcripts) and a Mouse Immunology Codeset (Nanostrings, NS_Immunology_C2269-547 transcripts) as indicated by manufacturer instructions.
Microarray experiment data treatment
Raw pixel intensity data acquired from scanning of the microarrays were background subtracted, log2 transformed and quantile normalized. Probes were filtered if they did not meet the 0.05 quantile (5th percentile) threshold in at least 9 of 12 arrays and then imputed with 6.75111 (the value at the 5th percentile). The filtering removed 1117 probes leaving a total of 37,555 remaining probes. A one-way analysis of variance (ANOVA) was used to model the data and then to determine differentially expressed genes (DEGs), the following contrasts were performed: DMPO vs Ctrl; LPS vs Ctrl; DMPO + LPS vs LPS. DEGs lists obtained using a false discovery rate (FDR [24] ) < 0.05 and absolute fold change > 1.5 criteria were represented in a Venn diagram using Bioinformatics and Evolutionary Genomics web tool (http://bioin forma tics.psb.ugent .be/webto ols/Venn/) and in pie chart using Microsoft Excel 2007.
Functional analysis of DEG lists
Generated DEG list were analyzed using the Functional Annotation tool of DAVID (Database for Annotation, Visualization and Integrated Discovery, Bioinformatics Resources 6.8, NIAID/NIH), and Top KEGG pathways and Gene Ontology (GO) terms were listed. DEG lists were also analyzed using Functional Analysis tool of Ingenuity Pathway Analysis (IPA) Software (QUIAGEN). In summary, Associated Canonical Pathways, Top upstream regulators and Associated Networks from IPA results were used for this publication.
mRNA detection and analysis with nCounter
Gene expression was examined using the NanoString© platform (http://www.nanos tring .com) utilizing Nanostrings Mouse Immunology Codeset (NS_Immunology_C2269) consisting of 547 endogenous and 14 housekeeping genes. 50 ng of each total RNA sample was prepared as per the manufacturer's instructions. Gene expression was quantified on the nCounter Digital Analyzer TM and raw and normalized counts were generated with nSolver (v3.0) TM software. Data were normalized utilizing the manufacturer's positive and negative experimental control probes, as well as the housekeeping gene GAPDH. Results are expressed as mean value ± SEM. Effects were assessed using the Student's t test. A difference between treatment groups with P < 0.05 was considered statistically significant.
Preparation of cell lysates
Following treatments with LPS for the indicated times, RAW 264.7 cell activation was stopped by the removal of medium and addition of ice-cold PBS [25] . In brief, whole cell lysates were prepared and used to detect proteins of interest by Western blot. Cells were lysed with the CelLytic M lysis solution (Sigma) containing 1% (v/v) protease inhibitor cocktail (Amresco). Cell debris was removed by centrifugation at 12,000g for 15 min at 4 °C, and the resultant supernatant was stored at − 80 °C until use. Protein concentration in cell lysate was determined using a BCA protein assay kit (Pierce Labs, Rockford, IL) with bovine serum albumin as standard.
Western blot
Cell lysates were mixed with 4 × SDS NuPAGE sample loading buffer (Invitrogen). After heat denaturation, equal amounts of cellular proteins were separated on 4-12% reducing NuPAGE Bis-Tris Gels (Invitrogen), followed by electrotransfer onto a nitrocellulose membrane (0.2 µM pore size). After blocking with 5% non-fat milk in PBS, Western blot assay was performed by incubation with a primary antibody overnight at 4 °C, and then incubation with fluorescent goat anti-rabbit or goat anti-mouse IgG secondary antibody for 1 h at room temperature. The immunocomplexes were visualized using FluorChem HD2 imager (Alpha Innotech Corp., San Leandro, CA). Anti-IRF7 and anti-GAPDH antibodies were purchased from ABCAM. GAPDH was used as a loading control. Image was analyzed using free software ImageJ [26] .
IFN-β determination
To measure the production of IFN-β cytokine, RAW 264.7 cells were grown in 25-ml flasks and then treated with LPS and/or DMPO for 24 h. The culture medium was collected and INF-b concentration was assessed using the commercial Mouse IFN-β ELISA kit (Catalog #MIFNB0, R&D Systems, MN, USA).
Statistical analysis
Results are expressed as mean value ± s.e.m. Effects were assessed using the Student's t test. A difference between treatment groups with P < 0.05 was considered statistically significant.
Results
Effects of DMPO, LPS and DMPO + LPS on RAW 264.7 cells transcriptome
We have previously shown that DMPO decreases LPS-triggered M1-linked pro-inflammatory cytokine (IL-1β, IL-6 and TNF-α) and NO production in RAW 264.6 cells [21] . Herein we were able to reproduce those data by showing that incubation of RAW 264.7 cells for 24 h with a low concentration of LPS such as 1 ng/ml was enough to cause significant nitrite accumulation in the culture medium (Fig. 1a) . Furthermore, we show that addition of 50 mM DMPO to the culture medium dampens this LPS-induced nitrite accumulation (Fig. 1b) .
Our previous data showed that the reduction of nitrite accumulation in LPS-primed cells caused by DMPO was consistent with low-inducible nitric oxide synthase (iNOS) gene expression and reduction of MAPK signaling [21] , but the precise mechanism by which DMPO exerts its transcriptomic effects remains unknown. 5 Cells were treated with increasing amount of LPS. b RAW 264.7 cells were incubated with 1 ng/ml LPS in the presence or in the absence of 50 mM DMPO. After incubation for 24 h, nitrite concentration in the medium was determined using the Griess reaction. Results are shown as mean values ± s.e.m. from three independent experiments. Data were analyzed using the t test. *P value < 0.001 To achieve a deeper understanding of how DMPO causes its anti-inflammatory effects herein, we studied its transcriptional effects on resting macrophages in the presence or in the absence of DMPO using microarray technology. We also used RAW 264.7 cells treated for 6 h with or without 50 mM DMPO, in the presence or absence of 1 ng/ml LPS, to understand how DMPO modulates the transcriptional changes induced by LPS. After treatment, we isolated mRNA and analyzed the transcriptome using an Illumina® Mouse Genome chip. Data were obtained (Fig. 2) , background subtracted, normalized and statically treated using ONE-WAY ANOVA (FDR = 0.05) to generate lists of DEGs.
We graphed the lists of differentially expressed genes in a Venn diagram using Bioinformatics and Evolutionary Genomics web tool and the results showed 18 genes that were present in all three comparisons (Fig. 3a) . The treatment of RAW 264.7 cells with 50 mM DMPO for 6 h in absence of LPS resulted in 79 genes differentially expressed. 23 genes were up-regulated whereas 56 were downregulated (Fig. 3b) . The effect of LPS was analyzed as positive control for inflammatory activation and the data showed 949 genes differentially expressed respect to untreated cells, 543 were upregulated and 406 were downregulated (Fig. 3b) . Treatment with DMPO in the presence of LPS was also tested and gene expression was compared to the LPS condition. The analysis showed 215 genes, 54 upregulated and 161 downregulated with respect to LPS-treated cells (Fig. 3b) .
These results indicate that LPS treatment generates major changes in macrophage transcriptome with most genes upregulated (57%). Compared to LPS effect, DMPO by itself generates fewer changes in the transcriptome and these changes are predominately linked to downregulated gene expression (71%). When comparing DMPO + LPS vs LPS, 75% of genes were downregulated indicating that DMPO is clearly dampening the effects caused by LPS.
Functional analysis of DMPO effects on the transcriptome of RAW 264.7 cells in the absence of LPS (DMPO vs control DEGs)
To establish a relationship between the list of genes affected by DMPO and biological functions we used DAVID database for identifying enriched GO terms. Functional Annotation clustering showed that DMPO treatment affects those genes associated with response to viruses, immune system processes and negative regulation of Tolllike receptor signaling pathways among others (Table 1) .
To identify enriched biological pathways and upstream regulators that may be regulated by DMPO, we submitted the same gene list to IPA software. IPA results are summarized in Fig. 4 where cardiac β-adrenergic signaling, nitric oxide and interferon signaling are among the top associated canonical pathways ( Supplementary Fig. 1 ).
This analysis also predicted that transcription factors related to interferon (IRF7 and IRF3) and Toll-like receptors (TLR 3, 4 and 9) as upstream regulators (Table 2) . Their interactions with other related molecules are shown in Fig. 5 . Top associated network is shown in Supplementary Fig. 2 . Taking together, functional annotation clustering with DAVID database and functional analysis using IPA software surprisingly indicate that the effects of DMPO by itself are related to downregulation of immune process, in particular interferon signaling and Toll-like receptors. Fig. 6 and Supplementary Fig. 3 (Top-canonical pathways) and 4 (Top associated network). Upstream regulators are listed in Supplementary Table 2 and their interactions are showed in Fig. 7 . Taking together our data obtained using DAVID database and IPA software show unbiased results on LPS vs Control DEGs consistent with previously published results [27] .
Functional analysis of DMPO effects on the transcriptome of RAW 264.7 cells in the presence of LPS (DMPO + LPS vs LPS DEGs)
To understand the effects of DMPO on the transcriptome of LPS-primed macrophages, we submitted DMPO + LPS vs LPS DEGs to functional analysis using DAVID database and IPA software. Functional annotation clustering results are listed in Table 4 (GO terms) and Table 5 (KEGG pathways) .
These results indicate that the genes affected by DMPO in LPS-primed RAW 264.7 cells were related to cellular response to LPS, response to viruses and cellular response to IFN-β among other GO terms. These genes were also associated with TNF-α signaling pathway, Toll-like receptor and MAPK signaling pathway, among other KEGG pathways (Table 5 ). These data are consistent with DMPO affecting several signaling pathways triggered by LPS [27] . Moreover, IPA analysis showed TLR receptors (3, 4 and 9) as predicted upstream regulators ( Fig. 8 ; Table 6 ) and canonical pathways related to communication between immune cells as enriched ( Supplementary Fig. 5 ). Top associated network is displayed in Supplementary Fig. 6 . It is important to highlight that most of the upstream regulators are predicted as inhibitions (Table 6) , which is consistent with DMPO dampening the entire signaling related to TLRs-triggered activation by LPS. Figure 9 displays how the molecules predicted are related to each other and also shows the behavior of genes downstream of these interactions. CCL2, CCL7, IRF7 and CD40 are highlighted in green indicating downregulation of its mRNAs expression in the DMPO + LPS vs LPS comparison.
All together comparison analysis of DMPO + LPS vs LPS DEGS indicates that DMPO dampens LPS signaling in different molecular pathways (MyD88-dependent and TRIF-dependent).
Confirmation of MyD88-dependent pathway inhibition by DMPO in LPS-stimulated RAW 264.7 cells
To confirm the results obtained by microarray technology, the same experiment was used for gene expression analysis using nCounter® technology. Over 500 transcripts were analyzed, Fig. 10 shows the gene expression of molecules highlighted in IPA analysis (see Fig. 9 ) and present in DAVID functional clustering (see Tables 4, 5 ): CCL2, CCL7 proteins as well as cytokines such as IL-6 and TNF-α.
Ncounter® results are consistent with previously published data where Myd88-dependent signaling pathwayrelated proteins, such as inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), were measured at protein levels and functional activity together with IL-6 and TNF-α production by ELISA [21, 28] . Moreover, Fig. 10 results confirm the behavior of genes highlighted by functional analysis of DMPO + LPS vs LPS DEG list (see Tables 4, 5 ; see Fig. 9 ) related to MyD88-dependent pathway such as CCL2, CCL7, IL-6 and TNF-α.
Confirmation of TRIF-dependent pathway inhibition by DMPO in LPS-stimulated RAW 264.7 cells
To confirm data obtained by microarray technology related to TRIF-dependent signaling pathway inhibition, we determine the expression IRF7 and IFN-β mRNA using nCounter® technology (Fig. 11) . Moreover, we measure IRF7 protein levels by western blot and its activity by measuring IFN-β by ELISA technique.
Results showed in Fig. 11 indicate that the addition of DMPO has no effect on the IRF7 mRNA levels after 6 h of incubation (Fig. 11a ). However, DMPO was able to reduce the expression of IRF7 protein levels and IFN-β after 24 h of incubation (Fig. 11b-d) . Taking together these results are consistent with data obtained using microarray technology and functional analyses where LPS-triggered TRIF-dependent signaling was blocked by DMPO.
Discussion
Herein, we provide evidence about the transcriptomic effects of DMPO in RAW 264.7 macrophage-like cell line. We also show that DMPO dampens most of the transcriptomic changes caused by LPS in these cells. These evidences provide unbiased data about the mechanism-based effects of DMPO and possibly other nitrones with anti-inflammatory effects.
Nitrone spin traps such as PBN and DMPO were originally developed with the purpose of trapping and stabilizing free radicals, thus making possible their study by ERS or immuno-spin trapping [12, 13] . However, they have shown other properties that made them interesting for pharmacological application as anti-inflammatory drugs, in particular for modifying the phenotype of macrophages toward a Codeset (NS_Immunology_C2269). Gene expression was quantified on the nCounter Digital Analyzer™ and raw and normalized counts were generated with nSolver (v3.0)™ software. Genes were normalized to GAPDH signal. One-way ANOVA test was used to determine statistical differences between conditions. *P < 0.01 M2-like anti-inflammatory phenotype. As of today DMPO or any of its structural analogs have not been moved into the drug development pipeline. On the other hand, PBNderived compounds have been probed in different models and have reached phase III clinical trials but mechanisms of its effects remain obscure [13] . This situation could be due to DMPO synthesis being really expensive in comparison with PBN and related compounds, and also because transcriptomic effects of DMPO on inflammatory cells remain ill defined. The production of mechanism-based drugs is an emerging field that will lead to safer drugs, especially antiinflammatory drugs. PBN and DMPO have been probed to have anti-inflammatory properties on several experimental models. Both spin traps are able to dampen LPS-triggered signaling related to MAPK, Akt, iNOS, COX-2 and pro-inflammatory cytokines [21, 29] suggesting that these effects may be related its nitrone motifs. Moreover, these anti-inflammatory effects cannot be explained by the superoxide radical anion scavenging properties of the spin trap due to a low reaction rate constant in both cases [22] . It has been suggested that DMPO reacts with protein-and DNA-centered radicals thus interfering with the chain reaction for radical production and redox-dependent signaling process [18, 20] . In vivo, DMPO competes with natural antioxidant molecules (such as glutathione and l-ascorbate) for free radicals and radicalized macromolecules, thus high doses of the spin trap are needed to overcome the competing reactions [30] . These competing reactions have in most cases rate constants much larger than that of DMPO with macromolecule-centered radicals, Fig. 11 Confirmation of LPS-triggered TRIF-dependent (MyD88-independent) pathway inhibition by DMPO in macrophages. RAW 264.7 cells were cultured with 1 ng/ml LPS in the presence or in the absence of 50 mM DMPO for: a IRF7 mRNA levels at 6 h after stimulus using nCounter® technology as described in Fig. 10 ; b Most representative western blot image of three independent experiments where IRF7 protein expression was measured; c IRF7 protein determination by western blot at 24 h after stimulus. ImageJ software was used for measuring protein band's optical density. GAPDH was used as loading control. Results are displayed as average of three independent experiments; d IFN-β secretion after 24 h stimulus measured by ELISA technique. Results are displayed as average of three independent experiments. *P < 0.01 thus formation of nitrone adducts is a kinetically unfeasible process. Currently the exact mechanism by which spin traps exert their anti-inflammatory effect remains unknown.
With the purpose of achieving a better understanding on how DMPO affects macrophage's biology, we aimed at studying the transcriptome in a wider approach using microarray technology. First, we analyzed the effect of 50 mM DMPO incubation for 6 h on RAW 264.7 cells in the absence of LPS. DMPO was able to affect the expression levels of 80 genes (compared to control) with 71% of them being downregulated. Interestingly, functional analysis of these genes using functional annotation clustering (DAVID database) and IPA software indicates that DMPO affects the expression of genes related to negative regulation of immune system processes and inflammatory responses with IRF7 predicted as the top upstream regulator. DMPO was also able to upregulate genes encoding enzymes critically involved in GSH biosynthesis (Supplementary Fig. 1 ). These changes on the transcriptome cannot be explained by DMPO reacting with protein-centered radicals that are necessary for redoxdependent signaling in resting cells, because the affected genes are almost exclusively related to immune system processes. If DMPO would interfere with redox-dependent signaling, several other biological functions would be compromised, due to the promiscuity of free radical reactions.
Second, we analyzed the effects of the spin trap on the transcriptome of LPS-primed cells. When DMPO was added simultaneously with LPS on RAW 264.7 cells for 6 h, the overall gene expression changed in 215 genes of which 75% were downregulated when compared to LPS-stimulated cells. This transcriptomic profile indicates that DMPO is clearly dampening those transcriptomic effects triggered by LPS. Furthermore, we performed functional analysis on these genes using DAVID database and IPA software, and the results are consistent with DMPO interfering with both Myd88-dependent and TRIF-dependent pathways of TLR-4 activated by LPS (together with other TLRs) and transcription factors related to interferon predicted as inhibited upstream regulators. These observed effects in both activation pathways of TLR-4 signaling were consistent with nCounter® experiments, and with previously published data where we show that DMPO blocks LPS-triggered MyD88-dependent signaling in RAW 264.7 cells [21] . Moreover, we also confirmed the effects of DMPO on LPS-triggered TRIFdependent signaling pathway in macrophages at protein and activity levels (IRF7 and IFNβ).
Taking together the transcriptomic changes obtained in the presence or in the absence of LPS, we can conclude that the effects of DMPO are related to a negative regulation of immune system process, particularly TLRs and IRF signaling. Further studies to define specific sites where DMPO causes these transcriptomic effects are undergoing to provide a most robust mechanism of action for this old compound with novel therapeutic properties.
